AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 25684611
Drug: Game+Therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Game+Therapy
Trial: 16570004
Drug: Steroid withdrawal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Steroid withdrawal group
Trial: 10102962
Drug: Triple therapy
RxNorm normalized name: MigreLief Triple Therapy with Puracol Caplet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple therapy group
Trial: 7903214
Drug: Tertatolol 5
RxNorm normalized name: tertatolol 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tertatolol 5 mg plus diuretic
Trial: 3960619
Drug: Both groups
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both groups received 12.5 mg/L of zinc
Trial: 21105483
Drug: Subcutaneous morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous morphine (0.35 mg/kg)
Trial: 21105483
Drug: Group E
RxNorm normalized name: Prostaglandin group E
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group E (Intravenous)
Trial: 18681202
Drug: Sequential chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sequential chemotherapy and radiotherapy
Trial: 15938592
Drug: Interferon beta-1b
RxNorm normalized name: Interferon Beta-1B
DrugBank: Interferon beta-1b (DB00068)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Interferon beta-1b (250 microg subcutaneous) with a slow, four-stage, 4-week titration
Trial: 1574915
Drug: Combined immunization
RxNorm normalized name: Immune Globulin
DrugBank: Human immunoglobulin G (DB00028)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined immunization with purified Vero cell rabies vaccine and Typhim Vi
Trial: 1574915
Drug: Purified Vero
RxNorm normalized name: RAYON,PURIFIED
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Purified Vero cell rabies vaccine
Trial: 6397973
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg amphetamine sulfate
Trial: 6397973
Drug: 7.5 mg
RxNorm normalized name: biotin 7.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7.5 mg amphetamine sulfate
Trial: 6397973
Drug: 25 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 mg ephedrine hydrochloride
Trial: 6397973
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg ephedrine hydrochloride
Trial: 6397973
Drug: Active drug
RxNorm normalized name: Capillary active drug
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active drug (combined results of amphetamines and ephedrine)
Trial: 2671282
Drug: Adjuvant chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant chemotherapy alone
Trial: 17134627
Drug: GIK infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: GIK infusion (30% glucose, 50 IU of insulin, 80 mEq of potassium chloride infused at 1.5 ml/kg/hour over 24 hours)
Trial: 10971306
Drug: S-heparin (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: S-heparin (50 IU kg(‐1) via i.v.)
Trial: 10971306
Drug: Placebo (saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (saline via i.v. injection)
Trial: 1451221
Drug: Nicardipine infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicardipine infusion (0.5‐2.0 micrograms.kg‐1 x min‐1)
Trial: 1451221
Drug: hANP infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: hANP infusion (0.05‐0.2 microgram.kg‐1 x min‐1)
Trial: 19545976
Drug: Olanzapine (7.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olanzapine (7.5 mg)
Trial: 22311903
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of yohimbine (5.4 mg) and atomoxetine (18.0 mg)
Trial: 6103707
Drug: Flunitrazepam 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flunitrazepam 0.5 mg oral
Trial: 6103707
Drug: Flunitrazepam 1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flunitrazepam 1.0 mg oral
Trial: 6103707
Drug: Flunitrazepam 2.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flunitrazepam 2.0 mg oral
Trial: 6103707
Drug: Flunitrazepam i.m.
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flunitrazepam i.m. administration
Trial: 8081180
Drug: Flunitrazepam (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flunitrazepam (all doses)
Trial: 23375074
Drug: 200 μg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 μg potassium iodide (KI)/d
Trial: 23375074
Drug: 300 μg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 μg potassium iodide (KI)/d
Trial: 20549511
Drug: Isosorbide mononitrate
RxNorm normalized name: Isosorbide Mononitrate
DrugBank: Isosorbide mononitrate (DB01020)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isosorbide mononitrate (IMN) 40 mg
Trial: 20549511
Drug: Misoprostol 40
RxNorm normalized name: Misoprostol 400 microgram oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Misoprostol 40 mg vaginally
Trial: 16986383
Drug: Heparin (unfractionated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin (unfractionated or low-molecular-weight)
Trial: 25184864
Drug: Trivalent inactivated
RxNorm normalized name: diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Injection [Tdvax]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trivalent inactivated influenza vaccine (IIV3)
Trial: 8665548
Drug: Selegiline (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Selegiline (5 mg b.i.d.)
Trial: 2014933
Drug: Volmax, 8
RxNorm normalized name: Volmax, 8 mg oral tablet, extended release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Volmax, 8 mg bid
Trial: 2014933
Drug: Proventil Repetabs,
RxNorm normalized name: Proventil Repetabs, 4 mg oral tablet, extended release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Proventil Repetabs, 8 mg (as two 4-mg tablets) bid
Trial: 29203772
Drug: Peanut oral
RxNorm normalized name: Peanut Oral Powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Peanut oral challenge
Trial: 19762295
Drug: Other analgesic
RxNorm normalized name: OTHER ANALGESICS AND ANTIPYRETICS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Other analgesic procedures
Trial: 15347340
Drug: Bepotastine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bepotastine (10 mg twice a day)
Trial: 15347340
Drug: Cetirizine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cetirizine (10 mg once a day)
Trial: 15347340
Drug: Fexofenadine (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fexofenadine (60 mg twice a day)
Trial: 24303975
Drug: Olopatadine (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olopatadine (5 mg twice a day)
Trial: 9868589
Drug: Antioxidants from
RxNorm normalized name: antioxidant 119
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antioxidants from food; specific dosage and duration not available.
Trial: 9868589
Drug: Antioxidant therapy;
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antioxidant therapy; specific details not available.
Trial: 7993987
Drug: Two 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two 10 mg controlled-release nifedipine tablets (Adalat Retard, Bayer), administered 12 hourly
Trial: 7993987
Drug: One 20
RxNorm normalized name: DIMETHICONE 20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: One 20 mg controlled-release nifedipine tablet (Adalat Retard, Bayer), administered 12 hourly
Trial: 7993987
Drug: Two 30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two 30 mg nifedipine gastro-intestinal therapeutic system (GITS) tablets (Adalat XL, Bayer), administered once daily
Trial: 7993987
Drug: One 60
RxNorm normalized name: apazone 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: One 60 mg nifedipine GITS tablet (Adalat XL, Bayer), administered once daily
Trial: 7993987
Drug: One 20
RxNorm normalized name: DIMETHICONE 20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: One 20 mg plus one 10 mg nifedipine controlled-release tablet (Adalat Retard, Bayer), administered 12 hourly
Trial: 18834731
Drug: Oral diazepam
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral diazepam 10 mg (n = 65)
Trial: 10812581
Drug: ciprofibrate 100
RxNorm normalized name: ciprofibrate 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ciprofibrate 100 mg
Trial: 1290434
Drug: Danazol 200
RxNorm normalized name: danazol 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Danazol 200 mg maintenance dose
Trial: 21922202
Drug: 4 mg
RxNorm normalized name: lutein 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 mg betamethasone i.v. prior to vinorelbine infusion
Trial: 21922202
Drug: Placebo i.v.
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo i.v. prior to vinorelbine infusion
Trial: 21922202
Drug: 20 ml
RxNorm normalized name: Exact-Med, 20 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 ml saline infusion post vinorelbine infusion
Trial: 20076843
Drug: Low-intensity warfarin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-intensity warfarin therapy (INR target 1.8, range 1.5-2.0)
Trial: 20076843
Drug: Standard-intensity warfarin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard-intensity warfarin therapy (INR target 2.5, range 2.0-3.0)
Trial: 20076843
Drug: Low-intensity warfarin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-intensity warfarin therapy
Trial: 20076843
Drug: Standard-intensity warfarin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard-intensity warfarin therapy
Trial: 15827573
Drug: OROS MPH
RxNorm normalized name: MPH
DrugBank: Methylphenidate (DB00422)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: OROS MPH 18 mg
Trial: 15827573
Drug: OROS MPH
RxNorm normalized name: MPH
DrugBank: Methylphenidate (DB00422)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: OROS MPH 54 mg
Trial: 9835257
Drug: Aspirin (n
RxNorm normalized name: ACETAMINOPHEN 250 mg / ASPIRIN 250 mg / CAFFEINE 65 mg ORAL TABLET, FILM COATED [EXCEDRIN MIGRAINE acetaminophen, aspirin (nsaid) and caffeine]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin (n = 30)
Trial: 9835257
Drug: Combined aspirin
RxNorm normalized name: Aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Combined aspirin and ticlopidine (nonrandomized group III, n = 31)
Trial: 28128982
Drug: Armodafinil (a
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Armodafinil (a wakefulness promoting agent)
Trial: 26010952
Drug: Hyperbaric oxygen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hyperbaric oxygen therapy (HBOT) - 40 sessions, 5 days/week, 90 minutes, 100% oxygen at 2ATA
Trial: 15982142
Drug: Individual therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Individual therapy (IT)
Trial: 19793724
Drug: Intranasal diamorphine
RxNorm normalized name: Diamorphine
DrugBank: Diamorphine (DB01452)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal diamorphine (0.1 mg/kg)
Trial: 9132194
Drug: Intramuscular morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular morphine (0.2 mg/kg)
Trial: 17302079
Drug: Intranasal diamorphine
RxNorm normalized name: Diamorphine
DrugBank: Diamorphine (DB01452)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal diamorphine
Trial: 3539046
Drug: 12 mg
RxNorm normalized name: pectin 12 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 12 mg of ivermectin in a single dose
Trial: 3539046
Drug: 1300 mg
RxNorm normalized name: gelatin 1300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1300 mg of diethylcarbamazine over eight days
Trial: 30250339
Drug: Single-dose del
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-dose del Nido cardioplegia (DNC)
Trial: 15863546
Drug: E+P (0.625
FDA approved: no
EMA approved: no
PMDA approved: no
Description: E+P (0.625 mg conjugated equine estrogens plus 2.5 mg medroxyprogesterone acetate)
Trial: 7622762
Drug: Placebo 2
RxNorm normalized name: Ethinyl Estradiol/Norethindrone Acetate;Placebo 20 MCG-1 MG; NA Oral Tablet, Disintegrating
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo 2 puffs four times daily
Trial: 3900856
Drug: Oral carbamazepine
RxNorm normalized name: Carbamazepine
DrugBank: Carbamazepine (DB00564)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral carbamazepine
Trial: 16750449
Drug: Valdecoxib 20
RxNorm normalized name: valdecoxib 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valdecoxib 20 mg BID
Trial: 17692722
Drug: Naproxen 500
RxNorm normalized name: naproxen 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naproxen 500 mg BID
Trial: 29962366
Drug: Standard community
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard community treatment
Trial: 2836059
Drug: i.v. melphalan
FDA approved: no
EMA approved: no
PMDA approved: no
Description: i.v. melphalan with concomitant oral misonidazole
Trial: 29710726
Drug: ADD-discontinuation group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ADD-discontinuation group (N=35)
Trial: 27183075
Drug: Microthreaded coronal
RxNorm normalized name: Corona Udder Butter
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Microthreaded coronal aspect implants (Hexplant)
Trial: 27183075
Drug: Rough-surface implants
RxNorm normalized name: rough marshelder pollen extract
DrugBank: Iva annua pollen (DB10927)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rough-surface implants (Brånemark)
Trial: 27183075
Drug: Machined coronal
RxNorm normalized name: Corona Udder Butter
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Machined coronal aspect implants (Restore)
Trial: 26092063
Drug: Teriparatide 20
RxNorm normalized name: TERIPARATIDE 200UNT/VIL INJ
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Teriparatide 20 μg per day
Trial: 26092063
Drug: Teriparatide 40
RxNorm normalized name: Teriparatide
DrugBank: Teriparatide (DB06285)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Teriparatide 40 μg per day
Trial: 26092063
Drug: Teriparatide (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Teriparatide (20 or 40 μg per day combined)
Trial: 19050299
Drug: AMA1-based vaccines
RxNorm normalized name: covid-19, RNA-based vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AMA1-based vaccines
Trial: 16880017
Drug: Multidisciplinary treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multidisciplinary treatment of MTBI
Trial: 1892362
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of dipyridamole, 75 mg, and acetylsalicylic acid, 330 mg, three times a day
Trial: 2206782
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of dipyridamole and acetylsalicylic acid
Trial: 30284700
Drug: 1% FIT039
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1% FIT039 patch
Trial: 30284700
Drug: 3% FIT039
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3% FIT039 patch
Trial: 9647029
Drug: Ciprofloxacin 500
RxNorm normalized name: ciprofloxacin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ciprofloxacin 500 mg twice daily for 7 days
Trial: 22726802
Drug: Ciprofloxacin 500
RxNorm normalized name: ciprofloxacin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ciprofloxacin 500 mg twice daily for 14 days
Trial: 30018129
Drug: Standard-of-care (SOC)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard-of-care (SOC) chemotherapy
Trial: 26747438
Drug: True bifurcation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: True bifurcation lesions (TBL) treated with second-generation drug-eluting stents (DES)
Trial: 26747438
Drug: Non-true bifurcation
RxNorm normalized name: Tavist Non-Sedating
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-true bifurcation lesions (non-TBL) treated with second-generation drug-eluting stents (DES)
Trial: 17515743
Drug: Low-intensity intramuscular
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-intensity intramuscular electrostimulation applied to the myofascial trigger point (MTP) with an interstimulus interval of 0.5 s.
Trial: 7974947
Drug: Yohimbine (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Yohimbine (15 mg per day orally) and trazodone (50 mg per day orally)
Trial: 4609555
Drug: Tetrabrom‐o‐methyl phenol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tetrabrom‐o‐methyl phenol (0.1%) after six treatments
Trial: 1969436
Drug: 4% chlorhexidine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4% chlorhexidine detergent solution
Trial: 18642974
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg long-acting risperidone administered intramuscularly once a month
Trial: 10801241
Drug: Alprazolam with
RxNorm normalized name: Alprazolam
DrugBank: Alprazolam (DB00404)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Alprazolam with low-dose ritonavir (200 mg, four doses)
Trial: 6734709
Drug: Oral contraceptive
RxNorm normalized name: VCF Contraceptive
DrugBank: Nonoxynol-9 (DB06804)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral contraceptive steroids
Trial: 8653994
Drug: Non-users of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-users of oral contraceptive steroids
Trial: 6144975
Drug: Aspirin (ASA,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin (ASA, 100 mg daily)
Trial: 27733107
Drug: Mycophenolate mofetil
RxNorm normalized name: Mycophenolate Mofetil
DrugBank: Mycophenolate mofetil (DB00688)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Mycophenolate mofetil (2000 mg/d)
Trial: 27733107
Drug: Mizoribine (12
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mizoribine (12 mg/kg/d)
Trial: 23039171
Drug: Imatinib mesylate
RxNorm normalized name: Imatinib Mesylate
DrugBank: Imatinib (DB00619)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Imatinib mesylate 400 mg daily for 6 months
Trial: 12567797
Drug: Cognitive Behavioural
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive Behavioural Therapy (CBT), 12 sessions
Trial: 2486583
Drug: 0.125% bupivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.125% bupivacaine at 20 ml/hr (25 mg/hr)
Trial: 2486583
Drug: 0.25% bupivacaine
DrugBank: Bupivacaine (DB00297)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 0.25% bupivacaine at 10 ml/hr (25 mg/hr)
Trial: 16163445
Drug: Standard axillary
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard axillary treatment (level I‐III axillary lymph node dissection or four node sampling)
Trial: 30107241
Drug: Internet-delivered exposure
RxNorm normalized name: Bacillus anthracis strain V770-NP1-R antigens
DrugBank: Anthrax vaccine (DB11003)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Internet-delivered exposure therapy (iExp)
Trial: 22683195
Drug: Iodixanol 320
RxNorm normalized name: IODIXANOL 320mgI/ml INJ
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iodixanol 320 mgI/mL (125 mL)
Trial: 18754720
Drug: Placebo light
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo light treatment
Trial: 24438695
Drug: Concurrent chemoradiotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concurrent chemoradiotherapy (group B)
Trial: 7943791
Drug: Fast injection
RxNorm normalized name: Fast Freeze
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fast injection rate (0.5 mL/s) of 0.3% hypobaric bupivacaine
Trial: 11590524
Drug: Nelfinavir-containing therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nelfinavir-containing therapy (PI treatment)
Trial: 11590524
Drug: RTI therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RTI therapy alone
Trial: 25099924
Drug: Sodium nitroprusside
RxNorm normalized name: Sodium Nitroprusside
DrugBank: Nitroprusside (DB00325)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Sodium nitroprusside (SNP) administered by continuous infusion and titrated to maintain BP control
Trial: 20353588
Drug: Epoprostenol infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epoprostenol infusion for 24 hours
Trial: 30557377
Drug: Placebo infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo infusion for 24 hours
Trial: 18029928
Drug: Chemotherapy with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy with or without radiotherapy
Trial: 25290658
Drug: Integrated Cognitive‐Behavioral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Integrated Cognitive‐Behavioral Therapy
Trial: 20598832
Drug: Twelve‐Step Facilitation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Twelve‐Step Facilitation Therapy
Trial: 22200721
Drug: Shenfu Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Shenfu Injection (SHF) post-treatment group
Trial: 12627928
Drug: Cefepime 2
RxNorm normalized name: cefepime 2000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefepime 2 g intravenously every 12 hours
Trial: 10816399
Drug: Captopril renography
RxNorm normalized name: Captopril
DrugBank: Captopril (DB01197)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Captopril renography (25 mg oral dose)
Trial: 6151528
Drug: 60 mg
RxNorm normalized name: opium 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 mg b.d.
Trial: 6151528
Drug: 120 mg
RxNorm normalized name: papain 120 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 120 mg b.d.
Trial: 20626264
Drug: LEDT treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LEDT treatment
Trial: 7995828
Drug: Triiodothyronine (0.15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triiodothyronine (0.15 microgram/kg bolus infusion after aortic cross-clamp removal; 0.1 microgram/kg before end of CPB; 0.1 microgram/kg at 4, 9, and 14 hours after CPB)
Trial: 2484510
Drug: Selenite, 200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Selenite, 200 micrograms daily